BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 24332055)

  • 1. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
    Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L
    Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
    Al-Khyatt W; Tufarelli C; Khan R; Iftikhar SY
    BMC Cancer; 2018 Feb; 18(1):121. PubMed ID: 29390981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
    Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
    Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
    Fan S; Liao Y; Qiu W; Li L; Li D; Cao X; Ai B
    Clin Transl Oncol; 2020 Nov; 22(11):2074-2086. PubMed ID: 32367494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
    Nakopoulou L; Lazaris AC; Panayotopoulou EG; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
    J Clin Pathol; 2004 May; 57(5):523-8. PubMed ID: 15113861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients.
    Alghamdi HI; Alshehri AF; Farhat GN
    J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S1-S6. PubMed ID: 29801587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD3, Cell proliferation and lymph nodes metastasis in breast cancer hormone-dependent.
    Oueslati M; Sassi N; Bettaieb I; Gamoudi A; Rahal K; Oueslati R
    Tunis Med; 2023 Feb; 101(2):273-279. PubMed ID: 37682272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management.
    Singh M; De Rubis G; Kokkinis S; Paudel KR; Yeung S; Hansbro PM; Oliver BGG; Dua K
    Pathol Res Pract; 2024 May; 257():155317. PubMed ID: 38657558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study.
    McMenamin ÚC; Trainor J; Coleman HG; McManus DT; McQuaid S; Bingham V; James J; Salto-Tellez M; Johnston BT; Turkington RC
    Oncotarget; 2018 Oct; 9(82):35300-35312. PubMed ID: 30450159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro.
    Tang H; Zhang Z; Zhu M; Xie Y; Lv Z; Liu R; Shen Y; Pei J
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review.
    Pinton G; Manzotti B; Balzano C; Moro L
    J Thorac Dis; 2021 Mar; 13(3):1851-1863. PubMed ID: 33841973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in Association of Estrogen and Human Non-small Cell Lung Cancer].
    He J; Song X
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):315-20. PubMed ID: 25975303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
    Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
    Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
    Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
    Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
    BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors, antiestrogens, and non-small cell lung cancer.
    Bogush TA; Dudko EA; Beme AA; Bogush EA; Kim AI; Polotsky BE; Tjuljandin SA; Davydov MI
    Biochemistry (Mosc); 2010 Dec; 75(12):1421-7. PubMed ID: 21314611
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.